NO985739D0 - Generering av molekyler som er replikative in vivo - Google Patents

Generering av molekyler som er replikative in vivo

Info

Publication number
NO985739D0
NO985739D0 NO985739A NO985739A NO985739D0 NO 985739 D0 NO985739 D0 NO 985739D0 NO 985739 A NO985739 A NO 985739A NO 985739 A NO985739 A NO 985739A NO 985739 D0 NO985739 D0 NO 985739D0
Authority
NO
Norway
Prior art keywords
vivo
generation
molecules
replicative
replicative molecules
Prior art date
Application number
NO985739A
Other languages
English (en)
Other versions
NO985739L (no
Inventor
Michel Perricaudet
Patrice Yeh
Hul Ne Leblois-Prehaud
Original Assignee
Rh Ne Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rh Ne Poulenc Rorer Sa filed Critical Rh Ne Poulenc Rorer Sa
Publication of NO985739L publication Critical patent/NO985739L/no
Publication of NO985739D0 publication Critical patent/NO985739D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/11043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
NO985739A 1996-06-12 1998-12-08 Generering av molekyler som er replikative in vivo NO985739D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607273A FR2749857B1 (fr) 1996-06-12 1996-06-12 Generation de molecules replicatives in vivo
PCT/FR1997/000914 WO1997047757A1 (fr) 1996-06-12 1997-05-23 Generation de molecules replicatives in vivo

Publications (2)

Publication Number Publication Date
NO985739L NO985739L (no) 1998-12-08
NO985739D0 true NO985739D0 (no) 1998-12-08

Family

ID=9492965

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985739A NO985739D0 (no) 1996-06-12 1998-12-08 Generering av molekyler som er replikative in vivo

Country Status (18)

Country Link
US (1) US6630322B1 (no)
EP (1) EP0906443B1 (no)
JP (1) JP2000511779A (no)
AT (1) ATE301721T1 (no)
AU (1) AU726442B2 (no)
BR (1) BR9709700A (no)
CA (1) CA2257916A1 (no)
CZ (1) CZ296600B6 (no)
DE (1) DE69733948T2 (no)
DK (1) DK0906443T3 (no)
ES (1) ES2248849T3 (no)
FR (1) FR2749857B1 (no)
HU (1) HU224175B1 (no)
IL (1) IL127430A0 (no)
NO (1) NO985739D0 (no)
SK (1) SK169898A3 (no)
WO (1) WO1997047757A1 (no)
ZA (1) ZA975134B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2720756B1 (fr) * 1994-06-02 1996-07-12 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2799472B1 (fr) 1999-10-07 2004-07-16 Aventis Pharma Sa Preparation d'adenovirus recombinants et de banques adenovirales
AU2001288839A1 (en) * 2000-09-08 2002-03-22 The General Hospital Corporation Self-rearranging dna vectors
AU2002325346A1 (en) 2001-07-05 2003-01-21 Aventis Pharma S.A. Method of administration of a gene of interest to the heart and vasculature
US7164056B2 (en) 2002-05-03 2007-01-16 Pioneer Hi-Bred International, Inc. Gene targeting using replicating DNA molecules
JP2012508591A (ja) * 2008-11-14 2012-04-12 ライフ テクノロジーズ コーポレーション 細胞を操作するための組成物および方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665543A (en) * 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
DE4228458A1 (de) * 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronische Expressionseinheiten und deren Verwendung
US5834256A (en) * 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
US6120764A (en) * 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
EP0632054A1 (en) * 1993-06-28 1995-01-04 European Molecular Biology Laboratory Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins
JP4216350B2 (ja) * 1994-09-19 2009-01-28 大日本住友製薬株式会社 動物細胞感染用の組換えｄｎａウイルスベクター
US5801030A (en) * 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
US6156497A (en) * 1996-01-05 2000-12-05 Genetic Therapy, Inc. Recombinase-mediated generation of adenoviral vectors

Also Published As

Publication number Publication date
ATE301721T1 (de) 2005-08-15
DE69733948D1 (de) 2005-09-15
AU3037797A (en) 1998-01-07
NO985739L (no) 1998-12-08
HUP9902585A3 (en) 2001-11-28
WO1997047757A1 (fr) 1997-12-18
BR9709700A (pt) 1999-08-10
JP2000511779A (ja) 2000-09-12
EP0906443B1 (fr) 2005-08-10
ES2248849T3 (es) 2006-03-16
CA2257916A1 (fr) 1997-12-18
DE69733948T2 (de) 2006-06-08
FR2749857B1 (fr) 1998-08-14
DK0906443T3 (da) 2005-12-19
CZ296600B6 (cs) 2006-04-12
SK169898A3 (en) 1999-07-12
HUP9902585A2 (hu) 1999-11-29
AU726442B2 (en) 2000-11-09
CZ402398A3 (cs) 1999-03-17
HU224175B1 (hu) 2005-06-28
ZA975134B (en) 1997-12-31
FR2749857A1 (fr) 1997-12-19
IL127430A0 (en) 1999-10-28
US6630322B1 (en) 2003-10-07
EP0906443A1 (fr) 1999-04-07

Similar Documents

Publication Publication Date Title
CY1105963T1 (el) Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης
ATE320503T1 (de) Komplementäre adenovirenvektorsysteme und zellinien
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
MXPA04004714A (es) Derivados de aril 1,4-pirazina sustituidos.
ATE288480T1 (de) Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
WO2000017771A3 (de) Verfahren zum konfigurieren eines konfigurierbaren hardware-blocks
DK0906443T3 (da) Generering af replikerende molekyler in vivo
AU2002320317A1 (en) Novel mesogens and methods for their synthesis and use
DE69933653D1 (de) Ribozyme die fähig sind die expression des ccr5 rezeptor zu hemmen
NO20002504L (no) Adenovirusvektorer og fremgangsmÕte for Õ redusere homologe rekombinasjonsfenomener
DK1123414T3 (da) Antisense-modulering af integrin alpha 4.ekspression
EP1012603A4 (en) FUNCTIONAL FRAGMENTS OF THE HIV-1 VPR PROTEIN AND METHODS OF USE
YU5800A (sh) Univerzalno primenljiva krvna plazma
AU1520701A (en) Segmented process for cleaning-in-place
ATE323166T1 (de) Fragmente der intron a von citomegalovirus
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
NZ510154A (en) A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics
WO2002097056A3 (en) Method for generating replication defective viral vectors that are helper free
ATE343329T1 (de) Verfahren zum herstellen von parboiled reis und charge von parboiled reis
WO1998018950A3 (de) Aav-dna mit helfervirus-sequenzen
DE69834422D1 (de) Klonierungsverfahren durch multiple verdauung
DE69726602D1 (en) Hepatitis b inhibitoren
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
DE69935215D1 (de) Neue glutaminase und entsprechendes gen, sowie verfahren zu deren herstellung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application